dc.contributor.author | Güneş, Hacı Murat | |
dc.contributor.author | Gökdeniz, Tayyar | |
dc.contributor.author | Kızılırmak Yılmaz, Filiz | |
dc.contributor.author | Demir, Gültekin Günhan | |
dc.contributor.author | Güler, Ekrem | |
dc.contributor.author | Güler Babür, Gamze | |
dc.contributor.author | Karaca, Oğuz | |
dc.contributor.author | Çakal, Beytullah | |
dc.contributor.author | Omaygenç, Mehmet Onur | |
dc.contributor.author | İbişoğlu, Ersin | |
dc.contributor.author | Boztosun, Bilal | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T19:58:22Z | |
dc.date.available | 10.07.201910:49:13 | |
dc.date.available | 2019-07-10T19:58:22Z | |
dc.date.issued | 2017 | en_US |
dc.identifier.citation | Güneş, H. M., Gökdeniz, T., Kızılırmak Yılmaz, F., Demir, G. G., Güler, E., Güler Babür, G. ... Boztosun, B. (2017). Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds. Journal of Interventional Cardiology, 30(3), 189-194. https://dx.doi.org/10.1111/joic.12386 | en_US |
dc.identifier.issn | 0896-4327 | |
dc.identifier.issn | 1540-8183 | |
dc.identifier.uri | https://dx.doi.org/10.1111/joic.12386 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/3157 | |
dc.description | WOS: 000405215800001 | en_US |
dc.description | PubMed ID: 28440067 | en_US |
dc.description.abstract | Objectives: We aimed to evaluate the peri-procedural success of DESolve bio-resorbable scaffolds (BRSs) and analyzed real-life data about major cardiac events during 1-year follow-up. Background: There is little information about real-life data of DESolve BRS which is a novel stent technology offering various advantages over drug eluting stents and commonly used in daily cardiology practice. Methods: We conducted this single-center and non-randomized cross-sectional study from June 2015 through August 2016 in Medipol University Department of Cardiology and included 117 patients undergoing single or multivessel percutaneous coronary interventions (PCI) with novolimus-eluting BRS devices (152 scaffolds) (Elixir Medical Corporation). Study end points were acute device and procedural success, scaffold thrombosis and major adverse cardiac event (MACE) rates of DESolve BRS. Results: Device success was 96.7% and procedural success was 99.3%. We detected MACE rate as 0.9% while clinical-driven target lesion revascularization was performed in one patient. None of the patients experienced scaffold thrombosis or death. Peri-procedural complications were reported in three patients. Conclusions: High rates of successful scaffold implantations, low rates of peri-procedural complications, and major cardiac events in long-term suggest that DESolve scaffolds can safely and effectively be used in daily intervention practice by particularly experienced operators. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Desolve BRS | en_US |
dc.subject | Device Success | en_US |
dc.subject | Major Cardiac Events | en_US |
dc.title | Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Journal of Interventional Cardiology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0001-5825-8627 | en_US |
dc.authorid | 0000-0003-1919-3183 | en_US |
dc.authorid | 0000-0001-9975-5507 | en_US |
dc.authorid | 0000-0002-4607-5724 | en_US |
dc.authorid | 0000-0002-4281-0867 | en_US |
dc.authorid | 0000-0003-0230-6575 | en_US |
dc.authorid | 0000-0003-2995-8792 | en_US |
dc.authorid | 0000-0002-4951-6716 | en_US |
dc.identifier.volume | 30 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 189 | en_US |
dc.identifier.endpage | 194 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1111/joic.12386 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.identifier.scopusquality | Q2 | en_US |